KSAT 12: COVID-19 numbers trending in the right direction, but more work still needed, infectious disease specialist says

Dr. Jan Patterson, Infectious Diseases, discussed several vaccine trials in San Antonio, including UT Health San Antonio becoming an approved site for the Novavax vaccine. She also mentioned that a new stage of the remdesivir trial has begun with patients receiving remdesivir plus an immunomodulator called Interferon Beta 1 Alpha.

Read and watch the story.



Share This Article!
Article Categories: COVID-19 Media Coverage, In the News